Sharon Bio-Medicine is currently trading at Rs. 44.50, up by 0.25 points or 0.56% from its previous closing of Rs. 44.25 on the BSE.
The scrip opened at Rs. 44.45 and has touched a high and low of Rs. 45.95 and Rs. 44.05 respectively. So far 335729 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 57.95 on 21-Feb-2014 and a 52 week low of Rs. 27.27 on 20-Nov-2013.
Last one week high and low of the scrip stood at Rs. 46.50 and Rs. 43.60 respectively. The current market cap of the company is Rs. 467.67 crore.
The promoters holding in the company stood at 60.20% while Non-Institutions held 39.80% stake in the company.
Sharon Bio-Medicine’s one of its unit located at MIDC, Taloja, Raigad district in state of Maharashtra has been allotted Good Laboratory Practice (GLP) Certificate which is on same line as Organization for Economic Co-operation & Development Certificate (OECD). With this, the company can do Toxicity & Mutagenicity Studies and Analytical & Clinical Chemistry Testing.
This will help the company to help big Pharma, Chemical & Agro companies to do research in their fields. Sharon will do the studies and testing in its laboratory for the companies all over the world which will improve the overall margins of the company.
Further, in last 6 months company’s other unit located at Dehradun has got UK MHRA and also another unit located at MIDC Taloja, Maharashtra has got EDQM. All these certifications / approvals will help company to sell its products to regulated countries.
No comments:
Post a Comment